TruClear Hysteroscopy and Papilocare Training Morning at Mayo University Hospital
Thank you to Mayo University Hospital‘s Gynaecology Team for inviting Premier Surgical & Premier Wellbeing to facilitate a training morning for Obgyn SpRs and SHOs to gain additional hands-on simulator and VR experience with the TruClear system.
It was also an opportunity to discuss the clinical data surrounding Papilocare‘s use for treating HPV-induced low grade cervical lesions.
Special thank you to Obgyn consultants on the day:
Dr Ulrich Bartels
Dr Anca Trulea
Dr Kamal Elmahi
For healthcare professionals interested in inviting Premier Surgical’s Gynaecology Team to facilitate a training workshop at your hospital, please contact [email protected].
About TruClear Hysteroscopy
Featuring fast, efficient resection and pathology optimised tissue removal devices, the TruClear™ system offers a complete technology platform for the removal of a range of intrauterine abnormalities. With more than 10 years of clinical experience, the TruClear™ system continues to set the standard for effective and safe tissue removal.
‘See & Treat’ Procedures
“The TruClear™ system overcomes one of the major hurdles in hysteroscopic polyp and fibroid removal, namely the safe extraction, under direct vision, of tissue specimens from the uterine cavity for histological assessment. Its small diameter, combined with its efficient, atraumatic mechanical action translates into short treatment times and a minimal surgical learning curve for those practitioners familiar with hysteroscopy. Research data support the use of the TruClear™ system in both the inpatient and office environment. Indeed our own randomised controlled trial showed that for the removal of endometrial polyps, the TruClear™ system is rapid, highly effective with a negligible failure rate and associated with both low pain scores and high rates of patient acceptability.
Strong evidence now supports the use of office based hysteroscopic surgery for common gynaecological conditions. The TruClear™ system further enhances the feasibility of convenient and efficient “see and treat” approaches to patient management. I am sure that mechanical hysteroscopic tissue removal will change the way we practise, expanding the adoption of office-based treatment and saving scarce health care resources by avoiding unnecessary hospital admission.
I would recommend that all clinicians develop efficient patient care pathways for the diagnosis and treatment of abnormal uterine bleeding, subfertility and uterine abnormalities utilising a “see-and-treat” policy where possible. I consider that the use of the TruClear™ system for the management of endometrial polyps, the commonest intrauterine pathology, integral to these contemporary developments.“
– Prof. Justin Clark M.D., Consultant Gynaecologist & Obstetrician, MBChB, MD (Hons), MRCOG
About Papilocare Vaginal Gel
Specifically formulated to repair HPV-induced low grade cervical lesions
Papilocare is a clinically proven class IIa medical device (non-prescription product) that is indicated for the treatment of HPV-induced ASCUS/LSIL cervical lesions. The use of Papilocare is recommended in women (over 18 years of age) infected by the human papillomavirus (HPV), independently of whether they have virus-induced lesions (ASCUS or LSIL).
Papilocare is distributed across the island of Ireland by Premier Surgical’s sister company Premier Wellbeing at www.premierwellbeing.ie. The code ‘PAPSTARTER’ can be used when purchasing the full 6-month application option to obtain the first month’s treatment free of charge.
